| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |